Business Context and Reporting Period
Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: UHS owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities. As of February 25, 2026, the company operated 375 inpatient facilities and 168 outpatient facilities across 40 U.S. states, Washington D.C., the United Kingdom, and Puerto Rico. Revenue is split approximately 57% from acute care and 43% from behavioral health services.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Net Revenues | $17.36 billion | $15.83 billion | +9.7% |
| Income from Operations | $1.99 billion | $1.68 billion | +18.6% |
| Operating Margin | 11.5% | 10.6% | +0.9 pts |
| Net Income Attributable to UHS | $1.49 billion | $1.14 billion | +30.4% |
| Diluted EPS | $23.10 | $16.82 | +37.3% |
| Operating Cash Flow | $1.86 billion | $2.07 billion | -9.8% |
| Total Debt (Carrying Value) | $4.75 billion | $4.50 billion | +5.6% |
| Debt-to-Capitalization | 40% | 40% | 0.0 pts |
Note: The increase in Net Income was significantly aided by a $93 million unrealized pre-tax gain on a minority investment in a healthcare generative AI company.
Material Changes vs. Prior Period
- Revenue Growth: Driven by a $1.25 billion increase in "Same Facility" operations and $287 million from new facilities (West Henderson Hospital in Las Vegas and Cedar Hill Regional Medical Center in Washington, D.C.).
- Profitability: Operating margin expanded to 11.5% from 10.6%, supported by volume growth and a decrease in interest expense ($156 million in 2025 vs. $186 million in 2024) due to refinancing activities.
- Segment Performance:
- Acute Care: Same facility revenues increased 8.5%; income before taxes increased 32%.
- Behavioral Health: Same facility revenues increased 7.7%; income before taxes increased 8.8%. UK behavioral health revenues reached $1.001 billion.
- Uncompensated Care: Total uncompensated care (charity care and uninsured discounts) rose to $3.95 billion in 2025 from $3.50 billion in 2024.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Capital Allocation: The Board authorized a $1.5 billion increase to the stock repurchase program in October 2025. The company repurchased approximately 4.65 million shares for $899 million during 2025. Dividends of $0.80 per share were paid.
- Capital Expenditures: Expected to spend $950 million to $1.1 billion in 2026 on equipment, construction, and renovations.
- Debt Refinancing: $700 million of 1.65% senior notes mature in September 2026. Management expects to refinance at significantly higher interest rates, which will increase interest expense and decrease net income.
Material Risks and Contingencies
- Legislative Impact (OBBBA): The "One Big Beautiful Bill Act" (enacted July 4, 2025) imposes work requirements for Medicaid and limits provider taxes. UHS estimates this will reduce aggregate annual net benefit from Medicaid supplemental programs by $432 million to $480 million by 2032.
- Legal Proceedings:
- Cumberland Litigation: A jury awarded $60 million in compensatory damages and $180 million in trebled damages (plus punitive damages) against a subsidiary regarding allegations of sexual misconduct. The company was dismissed from the initial trial but remains a defendant in approximately 40 additional pending cases. Insurance coverage for the 2020 policy year is approximately $143 million.
- Pinnacle Litigation: A jury awarded $4.7 million in compensatory damages and $500 million in punitive damages (expected to be reduced to ~$14 million) against a subsidiary. An $18 million legal reserve was recorded in Q3 2025.
- Regulatory & Operational: Risks include potential reductions in Medicare/Medicaid funding, increased labor costs due to staffing shortages, and exposure to tariffs on imported medical supplies.
Investor Verification Checklist
- Medicaid Exposure: Verify the specific impact of the "One Big Beautiful Bill Act" on state-specific supplemental payment programs (Texas, Nevada, California) and the timeline for revenue reductions.
- Legal Reserves: Monitor the status of the Cumberland and Pinnacle litigation appeals and the adequacy of the $449 million self-insured liability reserve.
- Debt Refinancing: Track the refinancing of the $700 million 2026 Notes and the resulting impact on interest expense and net income.
- Unrealized Gains: Assess the sustainability of earnings given the $93 million non-cash gain from the AI investment, which significantly boosted 2025 net income.
- Uncompensated Care: Review trends in charity care and uninsured discounts, which increased by $452 million year-over-year.